Most Recent
Class action investigation underway against Melbourne gynaecologist
A Melbourne gynaecologist faces a possible class action by women who claim they underwent unnecessary endometriosis surgeries.
Mayne Pharma sues Cosette over failed $672M merger
ASX-listed Mayne Pharma has taken US drug maker Cosette to court seeking "substantial damages" over the termination of their $672 million merger.
AstraZeneca wins injunction against Pharmacor’s generic diabetes drug
AstraZeneca has won an interlocutory injunction barring Pharmacor from making a generic version of its blockbuster diabetes drug Forxiga while a patent case over the drug proceeds.
ACCC clears Ramsay Health acquisition of National Capital
Private hospital operator Ramsay Health has won swift ACCC approval for its $251 million acquisition of Canberra hospital National Capital Private Hospital from Healthscope, with the regulator completing its review in three weeks.
St Vincent’s Hospital hit with underpayments class action
One of the firms that secured a record $230 million settlement in a class action on behalf of NSW doctors is still on the case, firing off a class action against Sydney's St Vincent's Hospital for allegedly underpaying junior doctors.
Millionaire cosmetic surgeon found guilty of professional misconduct
A tribunal has found millionaire property mogul and cosmetic surgeon Jerry Schwartz guilty of professional misconduct, after finding he inappropriately treated himself and four family members and flouted registration conditions by administering fentanyl to patients.
AstraZeneca sues Pharmacor over plan to launch generic diabetes drug
AstraZeneca has sued Pharmacor over its plans to list a generic version of blockbuster diabetes drug Forxiga on the PBS, but the drug maker will have to defend the validity of the patent, which was struck down by a UK court last year. 
NSW solicitors now eligible for free couples counselling
NSW's solicitor wellbeing service, SoWell, will now offer couples counselling, with the NSW Law Society acknowledging how the mental health challenges affecting legal professional can impact personal relationships.  
Merck fails to block Pfizer’s RSV vaccine trade mark
Merck KGaA has failed to block Pfizer’s 'Abrysvo' trade mark for its RSV vaccine, with a delegate finding no likelihood of confusion with the mark for Merck’s Mavenclad MS drug despite their visual similarities. 
‘Paradigm shift’: Otsuka says High Court must reverse patent extension ruling
Otsuka Pharmaceuticals has asked the High Court to overturn a decision revoking its Abilify patent extension, saying the ruling, which limited the extension-of term scheme to active substances only, will “lead to a groundswell of court proceedings”.